Literature DB >> 28183420

Circulating microRNA 216 as a Marker for the Early Identification of Severe Acute Pancreatitis.

Xiao-Xin Zhang1, Li-Hui Deng2, Wei-Wei Chen1, Na Shi1, Tao Jin1, Zi-Qi Lin1, Yun Ma1, Kun Jiang1, Xiao-Nan Yang1, Qing Xia3.   

Abstract

BACKGROUND: To study the value of circulating microRNA 216 (miR-216) as a marker for the severity of acute pancreatitis (AP) in both murine models and patients.
MATERIALS AND METHODS: Mice with AP were induced by intraperitoneal injection of 50μg/kg/hour cerulean either 7 times, sacrificed at 8, 9, 10, 11 or 12 hours after the first injection, or 12 times, sacrificed at 24 hours after the first injection. Plasma samples and data from patients with AP were obtained from a prospective cohort. Quantitative reverse transcription polymerase chain reaction was used to determine the miR-216a and miR-216b level.
RESULTS: The upregulation of miR-216a and miR-216b in the serum of mice was induced by cerulean injection in both the 7- and 12-injection groups (P < 0.05). The downregulation of miR-216a in pancreatic tissues of mice with AP was detected (P < 0.05), but no difference was observed in pancreatic miR-216b levels among any of the groups (all P > 0.05). The serum miR-216a level was positively correlated with pancreatic histopathology severity scores, and was negatively correlated with pancreatic miR-216a (r = -0.483, P = 0.009). The plasma miR-216a level was significantly upregulated in patients with severe AP (SAP) compared with patients with mild AP (MAP) or moderate severe AP (MSAP) (SAP versus MAP, P = 0.04; SAP versus MSAP, P = 0.00), but no difference was seen between patients with MAP and those with MSAP (P = 0.73).
CONCLUSIONS: Circulating miR-216a might be a potential biomarker for the early identification of SAP.
Copyright © 2017 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute pancreatitis; Biomarker; Severe acute pancreatitis; miR-216a; microRNA 216

Mesh:

Substances:

Year:  2016        PMID: 28183420     DOI: 10.1016/j.amjms.2016.12.007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  15 in total

1.  miR-135a deficiency inhibits the AR42J cells damage in cerulein-induced acute pancreatitis through targeting FAM129A.

Authors:  Kai-Kai Zhang; Shan-Shan Yu; Gui-Yun Li; Lian He; Xian-Quan Liang
Journal:  Pflugers Arch       Date:  2019-11-15       Impact factor: 3.657

2.  miR-216a-5p acts as an oncogene in renal cell carcinoma.

Authors:  Peijie Chen; Jing Quan; Lu Jin; Canbin Lin; Weijie Xu; Jinling Xu; Xin Guan; Zebo Chen; Liangchao Ni; Shangqi Yang; Yun Chen; Yongqing Lai
Journal:  Exp Ther Med       Date:  2018-02-20       Impact factor: 2.447

Review 3.  Multifactorial Scores and Biomarkers of Prognosis of Acute Pancreatitis: Applications to Research and Practice.

Authors:  Pedro Silva-Vaz; Ana Margarida Abrantes; Miguel Castelo-Branco; António Gouveia; Maria Filomena Botelho; José Guilherme Tralhão
Journal:  Int J Mol Sci       Date:  2020-01-04       Impact factor: 5.923

4.  Emodin Alleviates Sodium Taurocholate-Induced Pancreatic Acinar Cell Injury via MicroRNA-30a-5p-Mediated Inhibition of High-Temperature Requirement A/Transforming Growth Factor Beta 1 Inflammatory Signaling.

Authors:  Hong Xiang; Xufeng Tao; Shilin Xia; Jialin Qu; Huiyi Song; Jianjun Liu; Dong Shang
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

5.  Evaluation of Prognostic Factors of Severity in Acute Biliary Pancreatitis.

Authors:  Pedro Silva-Vaz; Ana Margarida Abrantes; Sara Morgado-Nunes; Miguel Castelo-Branco; António Gouveia; Maria Filomena Botelho; José Guilherme Tralhão
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

6.  Dysregulation of miR-192-5p in acute pancreatitis patients with nonalcoholic fatty liver and its functional role in acute pancreatitis progression.

Authors:  Yang Hu; Yongming Yu
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

Review 7.  Targeting MicroRNA Function in Acute Pancreatitis.

Authors:  Hong Xiang; Xufeng Tao; Shilin Xia; Jialin Qu; Huiyi Song; Jianjun Liu; Dong Shang
Journal:  Front Physiol       Date:  2017-09-21       Impact factor: 4.566

8.  Evaluation of Circulating MicroRNA Biomarkers in the Acute Pancreatic Injury Dog Model.

Authors:  Han-Byul Lee; Hyun-Kyu Park; Hyun-Ji Choi; Sora Lee; Sang-Joon Lee; Ji-Young Lee; Eun-Ho Cho; Hyo-Jeong Han; Ju-Hyung Seok; Woo-Chan Son
Journal:  Int J Mol Sci       Date:  2018-10-06       Impact factor: 5.923

9.  MicroRNA-9 modified bone marrow-derived mesenchymal stem cells (BMSCs) repair severe acute pancreatitis (SAP) via inducing angiogenesis in rats.

Authors:  Daohai Qian; Guodong Song; Zhilong Ma; Guannan Wang; Lei Jin; Minghua Hu; Zhenshun Song; Xiaoming Wang
Journal:  Stem Cell Res Ther       Date:  2018-10-25       Impact factor: 6.832

Review 10.  MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers.

Authors:  Yixin Yang; Christopher Alderman; Ayoub Sehlaoui; Yuan Xiao; Wei Wang
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.